We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.98%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$480M
AUM Growth
+$96.7M
(+25%)
Cap. Flow
+$82.2M
Cap. Flow
% of AUM
17.13%
Top 10 Holdings %
Top 10 Hldgs %
19.96%
Holding
645
New
258
Increased
78
Reduced
78
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$45.7M |
| 2 |
Nasdaq
NDAQ
|
+$5.95M |
| 3 |
Fidelity National Information Services
FIS
|
+$5.66M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$5.09M |
| 5 |
Novartis
NVS
|
+$5.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$5.84M |
| 2 |
ExxonMobil
XOM
|
+$5M |
| 3 |
CrowdStrike
CRWD
|
+$4.96M |
| 4 |
British American Tobacco
BTI
|
+$4.57M |
| 5 |
Blackstone
BX
|
+$4.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.69% |
| 2 | Consumer Discretionary | 15.64% |
| 3 | Healthcare | 14.23% |
| 4 | Financials | 8.55% |
| 5 | Communication Services | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Vaxcyte
PCVX
$8.03B
| $361K | 0.08% |
9,636
-2,925
| -23% | -$124K |
|
302
Iovance Biotherapeutics
IOVA
$2B
| $360K | 0.08% |
58,924
-151,476
| -72% | -$1.05M |
|
|
FSR
303
DELISTED
Fisker Inc.
FSR
| $359K | 0.07% |
58,415
+5,156
| +10% | +$35.5K |
|
304
Teekay Tankers
TNK
$2.59B
| $355K | 0.07% |
+8,264
| New | +$307K |
|
305
IDEX
IEX
$17.5B
| $352K | 0.07% |
+1,522
| New | +$346K |
|
306
iQIYI
IQ
$1.24B
| $350K | 0.07% |
+48,072
| New | +$330K |
|
|
LUCK
307
Lucky Strike Entertainment
LUCK
$916M
| $349K | 0.07% |
+20,572
| New | +$305K |
|
308
Franklin Resources
BEN
$17.8B
| $348K | 0.07% |
+12,924
| New | +$378K |
|
309
Veracyte
VCYT
$3.8B
| $347K | 0.07% |
+15,564
| New | +$376K |
|
310
New Oriental
EDU
$9.06B
| $347K | 0.07% |
8,975
-16,029
| -64% | -$648K |
|
311
Imperial Oil
IMO
$60.9B
| $343K | 0.07% |
+6,746
| New | +$337K |
|
312
Etsy
ETSY
$8.12B
| $342K | 0.07% |
+3,069
| New | +$381K |
|
313
DHT Holdings
DHT
$2.88B
| $339K | 0.07% |
31,392
-71,873
| -70% | -$722K |
|
314
DraftKings
DKNG
$10.8B
| $337K | 0.07% |
+17,404
| New | +$289K |
|
315
Cytokinetics
CYTK
$10.8B
| $332K | 0.07% |
+9,443
| New | +$385K |
|
316
Snap-on
SNA
$21.6B
| $330K | 0.07% |
+1,338
| New | +$327K |
|
317
FMC
FMC
$1.37B
| $329K | 0.07% |
+2,692
| New | +$339K |
|
318
Credicorp
BAP
$31.7B
| $326K | 0.07% |
+2,464
| New | +$331K |
|
319
Ecopetrol
EC
$34.5B
| $324K | 0.07% |
+30,729
| New | +$334K |
|
|
NEWR
320
DELISTED
New Relic, Inc.
NEWR
| $324K | 0.07% |
+4,300
| New | +$290K |
|
321
Wayfair
W
$14.4B
| $323K | 0.07% |
+9,415
| New | +$417K |
|
322
Star Bulk Carriers
SBLK
$3.12B
| $322K | 0.07% |
15,228
-2,794
| -16% | -$61.1K |
|
323
Patterson-UTI
PTEN
$3.73B
| $319K | 0.07% |
+27,239
| New | +$398K |
|
324
Nextpower Inc
NXT
$15B
| $318K | 0.07% |
+8,774
| New | +$278K |
|
325
Clearway Energy Class C
CWEN
$4.88B
| $317K | 0.07% |
+10,118
| New | +$325K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Seven Eight Capital held 645 positions worth $480M, up 25% from $383M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Seven Eight Capital deployed $82.2M of net new capital in Q1 2023, opening 258 new positions and adding to 78 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 114,438 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $5.84M trimmed.
- Seven Eight Capital's largest Q1 2023 buy was State Street SPDR S&P 500 ETF Trust: 114,438 shares worth $46.8M.
- Seven Eight Capital added most to BioMarin Pharmaceuticals in Q1 2023, an estimated $5.09M increase.
- Seven Eight Capital's biggest Q1 2023 reduction was Advanced Micro Devices, cutting an estimated $5.84M.
- Seven Eight Capital fully exited ExxonMobil in Q1 2023, selling an estimated $5M.
- Seven Eight Capital's ten largest holdings make up 20% of its $480M portfolio in Q1 2023.
- Seven Eight Capital opened 258 new positions and closed 231 in Q1 2023.
- Seven Eight Capital's portfolio value rose 25% quarter-over-quarter to $480M.
Based on Seven Eight Capital's 13F filing for Q1 2023, filed 15 May 2023.